雅斯B的总合成中的连续流技术:第二部分
Michal Gurský1, Dorotea Trnovcová1, Pavol Lopatka1
1Institute of Organic Chemistry, Catalysis and Petrochemistry, Slovak University of Technology, Radlinského 9, SK-812 37 Bratislava, Slovak Republic.
The Journal of organic chemistry
|September 25, 2025
概括
我们报告了使用催化碳化和连续流微反应器的斯宾B的总合成. 这种精简的方法证明了通过流体化学有效合成复杂的自然产品.
科学领域:
- 有机化学 有机化学
- 合成化学 合成化学
- 流动化学 流动化学
背景情况:
- 树B是一种复杂的天然产品,具有潜在的生物活性.
- 复杂分子的总合成对于药物发现和开发至关重要.
- 连续流化学为有机合成提供了效率,安全性和可扩展性的优势.
研究的目的:
- 为了实现莉花B的总合成,B.
- 实施一个催化碳化策略.
- 为了利用连续流微反应器技术来简化合成.
主要方法:
- 从加纳的化物开始的斯B的总合成.
- 在连续流条件下使用了Pd催化碳化策略.
- 在流量微反应器中使用维蒂格精,DiBAl-H降解,化和降解保护.
主要成果:
- 在流量微反应器中通过一系列反应成功合成莉花B.
- 使用酸和固定催化剂 (UBPS) 实现了高效的转移化.
- 开发了一种集和脱保护的多步流系统,并扩大了中间制备.
结论:
- 雅斯B的总合成使用连续流化学完成.
- 催化碳化和流量微反应器技术使得高效和精简的合成.
- 这种方法显示了复杂的自然产品可扩展合成的巨大潜力.
相关概念视频
Cycloaddition Reactions: Overview
3.4K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
3.4K
Pericyclic Reactions: Introduction
9.7K
Pericyclic reactions are organic reactions that occur via a concerted mechanism without generating any intermediates. The reactions proceed through the movement of electrons in a closed loop to form a cyclic transition state, where rearrangement of the σ and π bonds yields specific products.
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
Pericyclic reactions can be classified into three categories: electrocyclic reactions, cycloaddition reactions, and sigmatropic rearrangements. Electrocyclic reactions and sigmatropic...
9.7K
Multi-Step Reactions
8.6K
Chemical reactions often occur in a stepwise fashion involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs. Each of the steps in a reaction mechanism is called an elementary reaction. These...
8.6K
Step-Growth Polymerization: Overview
4.3K
Step-growth or condensation polymerization is a stepwise reaction of bi or multifunctional monomers to form long-chain polymers. As all the monomers are reactive, most of the monomers are consumed at the early stages of the reaction to form small chains of reactive oligomers, which then combine to form long polymer chains in the late stages. Hence, the reaction has to proceed for a long time to achieve high molecular weight polymers.
Many natural and synthetic polymers are produced by...
Many natural and synthetic polymers are produced by...
4.3K
Anionic Chain-Growth Polymerization: Mechanism
2.4K
The mechanism for anionic chain-growth polymerization involves initiation, propagation, and termination steps. In the initiation step, a nucleophilic anion, such as butyl lithium, initiates the polymerization process by attacking the π bond of the vinylic monomer. As a result, a carbanion, stabilized by the electron‐withdrawing group, is generated. The resulting carbanion acts as a Michael donor in the propagation step and attacks the second vinylic monomer, which acts as a Michael...
2.4K
Phase II Conjugation Reactions: Overview
766
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
766


